Skip to main content

Overview of NLRP3 Models

NLRP3 has arisen as a target of interest for Parkinson’s disease (PD) given increased levels seen in patient brain and preclinical studies showing inhibition of NLRP3 decreases pathology and motor deficits in preclinical models of PD. A number of models have been used in preclinical studies of NLRP3 in PD. In this overview document you will find a summary of those that are commonly used. Please note, this list is not comprehensive—others may be suitable for your research. 

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.